Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
Phase I and pharmacokinetic study of prinomastat, a matrix metalloprotease inhibitorKenneth R Hande, Mary Collier, Linda Paradiso, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
Developing an in-training examination for fellows: the experience of the American Society of Clinical OncologyFrances A Collichio, Karen M Kayoumi, Kenneth R Hande, et al.American Journal of Clinical Pathology|February 20, 2015
Liver metastases of small intestine neuroendocrine tumors: Ki-67 heterogeneity and World Health Organization grade discordance with primary tumorsChanjuan Shi, Raul S Gonzalez, Zhiguo Zhao, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
The pharmacokinetics and safety of ABT-751, a novel, orally bioavailable sulfonamide antimitotic agent: results of a phase 1 studyKenneth R Hande, Anne Hagey, Jordan Berlin, et al.American Journal of Clinical Oncology|April 8, 2006
Phase I/pilot study of SU5416 (semaxinib) in combination with irinotecan/bolus 5-FU/LV (IFL) in patients with metastatic colorectal cancerAlbert Craig Lockhart, Gillian F Cropp, Jordan D Berlin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
A phase I dose-escalation and pharmacokinetic study of brostallicin (PNU-166196A), a novel DNA minor groove binder, in adult patients with advanced solid tumorsA Craig Lockhart, Martin Howard, Kenneth R Hande, et al.Human Pathology|March 13, 2012
Morphologic and immunophenotypic analysis of desmoid-type fibromatosis after radiation therapyJustin M M Cates, Jennifer Black, Carmen C Wolfe, et al.Human Pathology|April 24, 2012
Signal transduction pathway analysis in fibromatosis: receptor and nonreceptor tyrosine kinasesJustin M M Cates, Jennifer O Black, Doha M Itani, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 25, 2012
Nuclear p63 expression in osteoblastic tumorsMichael E Kallen, Melinda E Sanders, Adriana L Gonzalez, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedulesGeorge D Demetri, Sant P Chawla, Margaret von Mehren, et al.Pageof 2